Trispecific anti-CLDN-18.2/CD3/CD28 antibodies for gastric cancer treatment
{{output}}
Claudin-18.2 is an overexpressed molecule in gastric cancer, which is why it is considered a potential therapeutic target. WO2024082060 describes trispecific antibodies directed against CDLN-18.2/CD3/CD28, and gastric cancer treatment method. These antibodies ... ...
